Updated
APTOSE BIOSCIENCES INC - NASDAQ: $APTO Rounding Bottom
Since October, shares of APTOSE BIOSCIENCES INC - NASDAQ:APTO appear to be forming a rounding bottom and recently, have witnessed the recapture of its 200 DMA as well as a noticeable pick-up in volume as we can observe from the Daily chart above.
In addition, APTO now finds itself trading above all of its important moving averages 20/50/200 DMA's, which is suggestive of a healthy technical posture.
While further work is required, both investors/traders may want to continue to monitor the action closely and in particular, should APTO be capable of taking-out the $2.45 figure at any point in the days/weeks ahead, such development may just trigger its next advance into higher ground with and initial $3 - $3.50 objective.
Nonetheless, the recent action in APTO is encouraging and both investors/traders may want to put the name front-and-center on their radars for further clues/evidence that things may be about to pick-up n earnest.
In addition, APTO now finds itself trading above all of its important moving averages 20/50/200 DMA's, which is suggestive of a healthy technical posture.
While further work is required, both investors/traders may want to continue to monitor the action closely and in particular, should APTO be capable of taking-out the $2.45 figure at any point in the days/weeks ahead, such development may just trigger its next advance into higher ground with and initial $3 - $3.50 objective.
Nonetheless, the recent action in APTO is encouraging and both investors/traders may want to put the name front-and-center on their radars for further clues/evidence that things may be about to pick-up n earnest.
Trade active
APTO delivers 138% gains in 6 months.Congrats to all who participated!
For real-time alerts, signup link in bio and bottom of chart.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.